drugset / Trial / NCT03722173
A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 894416 in the Blood
NaCrossoverOpen-labelTreatment
Summary
The main objective of this trial is to investigate the relative bioavailability of BI 894416 in plasma when given as oral single dose together with multiple oral doses of itraconazole (Test,T) as compared to when given alone as oral single dose (Reference, R).
Timeline
- Start
- 2018-11-13
- Primary completion
- 2018-12-14
- Completion
- 2018-12-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 894416 | Unknown | 3 mg | — |
| Subject | Itraconazole | Small molecule | 200 mg | Oral |
Indications
No indication recorded.